CARLSBAD, Calif., Sept. 13 /PRNewswire-FirstCall/ — Genoptix,
Inc. (Nasdaq: GXDX), a specialized laboratory services
provider, today announced the Company’s participation at the 2010
UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New
York City, to be held September 20-22, 2010.
President and CEO Tina S. Nova, Ph.D., and Sam Riccitelli, EVP
and COO of Genoptix, will present at the conference on Tuesday,
September 21, 2010 beginning at noon EDT, when they will provide an
overview of the Company’s specialized diagnostic laboratory
services business, growth strategies and financial performance.
The presentation is expected to last approximately 30 minutes
and will be webcast live through the “Investors” section of the
Genoptix website at www.genoptix.com. Those who
would like to listen to the presentation should go to this site at
least 15 minutes prior to the event to register, download and
install any necessary software. An audio replay will be available
for 30 days following the initial presentation webcast.
About Genoptix, Inc.
Genoptix is a leading specialized laboratory service provider
focused on delivering personalized and comprehensive diagnostic
services to its physician customers, community-based hematologists
and oncologists. On the forefront of personalized diagnostic
services, Genoptix’s highly trained group of hematopathologists
utilize sophisticated technology to provide integrated testing and
actionable diagnostic reports. Its diagnostic services are
designed to optimize the care of patients suffering from
hematomalignancies, or cancers of the blood and bone marrow,
including leukemia and lymphoma, and other forms of cancer.
Founded in 1999, Genoptix is a member of the Nasdaq Global
Select Market, the S&P SmallCap 600 Index and the Russell 2000
Index and is headquartered in Carlsbad, California. For more
information, please visit <
‘/>”/>
